The growth of the UK ligation devices market is significantly influenced by the adoption of minimally invasive surgical (MIS) techniques across healthcare facilities. Surgeons in the UK are increasingly transitioning from traditional open procedures toward MIS methods such as laparoscopy and robotic-assisted surgery due to their clinical benefits, including reduced trauma, shorter hospital stays, and quicker recovery times. This procedural shift has enhanced the demand for advanced ligation devices that offer precision, reliability, and compatibility with MIS equipment. Devices such as endoscopic clip appliers are witnessing significant demand as they provide enhanced visibility and control within confined anatomical spaces. Furthermore, NHS modernization efforts and ongoing investments in surgical infrastructure have improved access to advanced surgical technologies. The continuous refinement of surgical protocols and training programs is also ensuring that surgeons are proficient in the use of these devices, further boosting their utilization.
The aging population in the country is also one of the major factors driving the growth of the ligation devices market, as older adults usually experience a higher incidence of chronic and degenerative conditions that require surgical intervention. According to the Centre for Ageing Better 2025, around 19% of the total population or 11 million people in England are aged 65 years or above and around 38% of the total population or 22 million people are aged 50 years or above. Moreover, according to the same source, by 2065, around 26% of the population will be aged 65 years or above and around 46% of the population will be aged 50 years and above. With the growing proportion of individuals aged 65 and older, there is an increased demand for surgeries related to cardiovascular disease, cancer, gastrointestinal disorders, and urological complications, many of which necessitate reliable vessel ligation. Elderly patients often require minimally invasive or precisely controlled procedures to reduce surgical risks and recovery times, further fueling the need for advanced ligation devices that offer safety, and efficiency.
UK Ligation Devices Market Report Segmentation
This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the UK ligation devices market report based on product, application, procedure, and end-use:Product Outlook (Revenue, USD Million, 2021 - 2033)
- Appliers
- Disposable
- Reusable
- Accessories
- Clips
- Clip Remover
Application Outlook (Revenue, USD Million, 2021 - 2033)
- Gastrointestinal and Abdominal Surgery
- Gynecological Surgery
- Cardiothoracic Surgery
- Urological Surgery
- Other
Procedure Outlook (Revenue, USD Million, 2021 - 2033)
- Minimally Invasive Surgery (MIS)
- Laparoscopic
- Robotic Assisted
- Others
- Open surgery
End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Welfare Medical Ltd
- Grena Ltd
- Medtronic
- Fannin Ltd
- BioSpectrum Ltd
- Teleflex
- LocaMed Ltd
- Johnson & Johnson (Ethicon)
- B. Braun Melsungen
- Boston Scientific Corporation